AI System Detects Pancreatic Cancer 5 Years Before Symptoms Appear

Pancreatic cancer has long been one of the deadliest forms of cancer, largely because it's almost always detected too late. That may be about to change dramatically. Researchers at Johns Hopkins and Google Health have developed an AI system called EarlySignal that can detect pancreatic cancer biomarkers in routine blood work up to five years before conventional diagnosis. In clinical trials involving 200,000 patients, the system achieved 93% accuracy with less than 1% false positives. 'If we can catch pancreatic cancer at Stage 1 instead of Stage 4, the five-year survival rate jumps from 7% to over 80%,' said Dr. Robert Kim, the study's lead author. 'This AI could save 400,000 lives per year worldwide.' The FDA has fast-tracked the system for approval, and three major hospital networks have already begun pilot programs.